Viral Hepatitis in Asia and the Pacific
Towards Elimination as a Public Health Threat
- 1st Edition - March 25, 2025
- Imprint: Academic Press
- Editors: Jing Sun, Polin Chan, Yoke Ling Chee
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 2 3 6 2 9 - 7
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 2 3 6 3 0 - 3
Viral Hepatitis in Asia and the Pacific: Towards Elimination as a Public Health Threat documents the narratives, innovations, and scope of work in the Asia-Pacific region in starti… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteViral Hepatitis in Asia and the Pacific: Towards Elimination as a Public Health Threat documents the narratives, innovations, and scope of work in the Asia-Pacific region in starting, consolidating, and moving towards the elimination of viral hepatitis. The Asia-Pacific region is disproportionately affected by viral hepatitis, accounting for two-thirds of the global burden. Countries from low-, middle- and high-income economies have adopted different strategies to address combating and eliminating viral hepatitis. The successful experiences of the Asia-Pacific region are valuable for other regions, especially the middle- and low-income countries moving towards the achievement of the 2030 goal of elimination.
Strategies discussed include integrated approaches, negotiating universal access to diagnostics, and treatment options, including vaccines. Content further covers the critical barriers to achieve the 2030 targets for elimination of viral hepatitis and how to overcome them. This is the perfect reference for all hepatology researchers and elimination policy advocates who are dedicated to joining the fight for the 2030 goal of the elimination of viral hepatitis as a public health threat.
- Focuses on the elimination of viral hepatitis as a global target through learning strategies and approaches in countries where hepatitis is most common
- Provides the “how” behind the elimination of viral hepatitis, including integrated approaches and shifts in science and policy
- Presents updated information from multiple countries on the challenges and strategies that can be used toward the WHO’s goal of eliminating viral hepatitis
Hepatology researchers Hepatitis elimination policy advocates
- Title of Book
- Cover image
- Title page
- Table of Contents
- Copyright
- List of contributors
- Chapter 1. Epidemiology and response to viral hepatitis in Asia and the Pacific regions
- Abstract
- Introduction
- Burden of viral hepatitis in the South-East Asia region
- Burden of viral hepatitis in the Western Pacific region
- Response to hepatitis in the Asia-Pacific region
- Key challenges
- Key shifts required to end the epidemic of viral hepatitis by 2030
- Abbreviations
- References
- Chapter 2. Towards elimination of viral hepatitis B and C in Australia
- Abstract
- Introduction
- Hepatitis B in Australia
- Hepatitis C in Australia
- National strategies for hepatitis prevention in Australia
- Screening and diagnosis
- Treatment guidelines
- Access to treatment and healthcare services
- Challenges in screening, diagnosis, and management
- Conclusion
- Abbreviations
- References
- Chapter 3. Central pooled procurement and price negotiation: China’s strategies for affordable antiviral treatment of hepatitis B and C
- Abstract
- Background
- Objective
- Policy review
- Policy impact on antiviral treatment of hepatitis B and hepatitis C
- Challenges in achieving the goal of eliminating the public health hazards of viral hepatitis by 2030
- Conclusions
- Abbreviations
- References
- Chapter 4. Efforts towards elimination of viral hepatitis in India
- Abstract
- Viral hepatitis as public health concern
- National initiatives and policies
- State-specific initiatives
- Towards elimination in partnership with nongovernment organizations
- Challenges ahead and the way forward
- Conclusions
- Abbreviations
- References
- Chapter 5. Hepatitis B elimination in the Pacific Islands: models of care delivery in Kiribati
- Abstract
- Country profile
- Health situation
- Hepatitis B immunization
- Viral hepatitis situation
- National response and progress
- Scaling up access through the “test and treat or vaccinate” concept
- Challenges
- Future work
- Conclusion
- Abbreviations
- References
- Chapter 6. Government-led initiatives: a journey of enhancing hepatitis C treatment accessibility in Malaysia
- Abstract
- Background
- Malaysia’s key strategies to battle hepatitis C
- Malaysia’s achievement
- Malaysia’s opportunities
- Conclusion
- Abbreviations
- References
- Chapter 7. Viral hepatitis elimination in Mongolia
- Abstract
- Background
- Health care system
- Epidemiology of viral hepatitis in Mongolia
- Government’s public health response to the epidemic
- Effects of the government responses
- Challenges ahead
- Conclusions
- Abbreviations
- Acknowledgment
- References
- Chapter 8. Hepatitis B immunization
- Abstract
- Hepatitis B virus and vaccines
- Immunization programs in Asia and Pacific
- Reaching the hepatitis B control target through immunization
- Elimination of viral hepatitis and mother-to-child transmission of HBV
- Country success stories, challenges, and opportunities
- Way forward
- Abbreviations
- References
- Chapter 9. South-South partnerships in developing affordable DAAs for low- and middle-income countries
- Abstract
- Background
- Challenges and gaps in DAAs accessibility and affordability
- South-South partnerships, R&D and access
- Outcomes and lessons learned
- Conclusion
- Abbreviations
- References
- Chapter 10. The “how” of shifting a global paradigm: from dual to triple elimination of mother-to-child transmission of HIV, hepatitis B and syphilis
- Abstract
- Today’s progress is the result of hard-won iterative improvements
- Shifting the paradigm—ask the right question(s)
- Setting the vision and cocreating for collective buy-in
- “Let loose”: amplifying ideas to benefit many more
- Gaining ground: shaping country, regional and global actions
- Where are we today
- Conclusion
- Acknowledgment
- Abbreviations
- References
- Index
- Edition: 1
- Published: March 25, 2025
- Imprint: Academic Press
- No. of pages: 282
- Language: English
- Paperback ISBN: 9780443236297
- eBook ISBN: 9780443236303
JS
Jing Sun
Dr. Sun is the Professor for Pharmaceutical Policy of the Chinese Academy of Medical Sciences and Peking Union Medical College. Her research areas focus on pharmaceutical policy analysis and specialized in pharmaco-economics and pharmaco-epidemiology. She received her Ph.D. from the Graduate School of Medical Sciences at the University of Groningen of the Netherlands, MSc. of International Health Policy from London School of Economics of the UK, and Bachelor of Pharmaceutical Chemistry from Peking Medical University of China.
PC
Polin Chan
Dr Chan is the Regional Advisor for Hepatitis/HIV/STI in the World Health Organisation South-east Asia Regional Office (SEARO). She has served in countries and regions with WHO since 2005 in public health and communicable diseases prevention and control. Dr Chan graduated as a medical doctor from the University of Hong Kong, trained in women’s health, and in tropical medicine and epidemiology from the London School of Hygiene and Tropical Medicine.
YC
Yoke Ling Chee
Ms Chee is the Executive Director of Third World Network, a non-profit international policy research and advocacy organization involved in sustainable development issues. She is an international lawyer whose areas of expertise include the environmental, social and economic impacts of globalization, especially in countries of the South. She holds degrees from the University of Malaya (Malaysia) and Cambridge University (UK).
Read Viral Hepatitis in Asia and the Pacific on ScienceDirect